New Clinical Data Supports Viz.ai Solution for Improved Pulmonary Embolism Detection and Care...
Company’s Artificial Intelligence Technology Shows Better Results in Early Detection and Patient Care SAN FRANCISCO, CA – September 21 –...
Sep 21, 2023
All Resources
Explore our latest resources
September 20, 2023
September 13, 2023
Viz.ai to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
SAN FRANCISCO–Sept. 8, 2023 –Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced Chris Mansi, M.D.,...
Sep 08, 2023
Viz.ai Signs License Agreement with UCSF to Commercialize Three Cardiac Artificial Intelligence Algorithms
Exclusive agreement for AI algorithms to accelerate earlier detection of cardiac amyloidosis and pulmonary hypertension SAN FRANCISCO, CA – August...
Aug 25, 2023
Viz.ai Receives First De Novo Approval by the FDA for AI Algorithm for...
New artificial intelligence algorithm for earlier detection and management of hypertrophic cardiomyopathy SAN FRANCISCO, CA – August 15, 2023 -...
Aug 15, 2023
Unlocking the Future of Neurovascular Care: 3 Takeaways from the 2023 SNIS Annual...
The Society of Neurointerventional Surgery (SNIS) Annual Meeting showcased cutting-edge research and advancements in the field of neurovascular care. Here...
Aug 08, 2023